Dual Listed Biotech Begins to Prepare POC Preclinical Study for Diabetes & Obesity Dual Gene Therapy Program
04 12월 2023 - 10:00PM
AllPennyStocks.com
Obesity and diabetes have become a problem for developed world
countries. To address the global rise of these issues, this company
is pursuing a dual-gene therapy strategy using
proprietary...
To read the full story on AllPennyStocks.com, click
here.
PreveCeutical Medical (CSE:PREV)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
PreveCeutical Medical (CSE:PREV)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024
